TEC findings on the use of IVIg.
D003872:Dermatitis / Q000188:drug therapy; D006801:Humans; D007116:Immunization, Passive; D016756:Immunoglobulins, Intravenous; D009103:Multiple Sclerosis / Q000188:drug therapy; D013673:Technology Assessment, Biomedical
D016756:Immunoglobulins, Intravenous